George J Morrow sold $2.3M of NBIX stock

George J Morrow, Dir of Neurocrine Biosciences Inc (NBIX), sold 15,000 shares of NBIX stock worth $2.3M, per an SEC Form 4 filed Nov 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 30, 2026, 4 days before it was made public.

NBIX has moved +12.7% since the trade date, from $146.10 to $164.63 (Nov 6, 2026 close).